1.Identification of the related substances in docetaxel injection by LC-MS/MS.
Ya-Kun RAO ; Meng WANG ; Li DING ; Bing LIU ; Cheng JI ; Zheng-Yu YAN
Acta Pharmaceutica Sinica 2012;47(6):779-784
The related substances in docetaxel injection were identified by LC-MS/MS. Ethyl acetate was used to extract the injection to remove the pharmaceutical excipients. HPLC separation was carried out on a Hedera ODS-2 column (150 mm x 2.1 mm, 5 microm) with a mobile phase consisting of acetonitrile - 0.1% acetate acid aqueous solution (40: 60). Electrospray ionization source was set in the positive mode for the LC-ESI-MS/MS, and the ion monitoring modes were full scan and product ion scan. According to the mass spectra of the related substances, the fragment profiles were explained, and the chemical structures were elucidated. Docetaxel and its main related substances were well separated. Nine related substances in docetaxel injection were detected by LC-MS/MS. Their chemical structures were proposed, and four of them were identified in the docetaxel injection for the first time. The established LC-MS/MS method is effective in the separation and identification of the related substances in docetaxel injection. The test results are useful for its quality control.
Antineoplastic Agents
;
administration & dosage
;
analysis
;
chemistry
;
Chromatography, High Pressure Liquid
;
Drug Contamination
;
Injections
;
Molecular Weight
;
Quality Control
;
Spectrometry, Mass, Electrospray Ionization
;
Tandem Mass Spectrometry
;
Taxoids
;
administration & dosage
;
analysis
;
chemistry
2.Establishing an animal model to investigate depression with coronary heart disease
Guo CHUN-XIA ; Zheng FEI ; Feng YI-RAN ; Rao YU-DONG ; Zhang YING ; Ma ZONG-REN ; Zeng YAN-FANG ; Zhou HAO ; Yang KUN-RONG ; Ni WEI ; Zhang XUE-YA
Chinese Medical Journal 2019;132(24):3021-3023
3.Research on the impact of supply side policy coordination of medical insurance on cost control under DIP payment method
Kun-He LIN ; Ye-Sheng SHANGGUAN ; Ya-Qi RAO ; Jing PENG ; Yi CHEN ; Yi-Fan YAO ; Ying-Bei XIONG ; Li XIANG
Chinese Journal of Health Policy 2024;17(5):17-24
Objective:This study aims to explore the synergistic effects of DIP and other medical insurance supply-side policies.Method:City A that has piloted DIP reform was set as the treatment group,and City B without reform was set as the control group.A total of 1 120 public medical institution samples from 2019 to 2022 were collected.The total medical expenses during hospitalization and some structural expenses were analyzed using DID method.Result:DIP had a significant inhibitory effect on the medical expenses,and the expenses of checkups and examinations during hospitalization in city A,but had no impact on the drug and the material expenses during hospitalization.Conclusion:DIP played a significant cost control role and effectively controlled the total medical expenses during hospitalization.The synergistic effects of price adjustment of medical services policy and national centralized drug/material procurement policy on cost control were insufficient.DIP synergized with other supply-side policies to promote rational medical cost structure.It is suggested that medical insurance departments should focus on the synergistic effects of medical insurance supply-side policies to jointly improve the efficiency of medical insurance fund utilization.